/BLAC

BLAC Stock - Bellevue Life Sciences Acquisition Corp.

Q: What is the analyst price target for BLAC?

Analyst price target information is not currently available for BLAC.

Q: What is BLAC's market cap?

Market capitalization information is not currently available for BLAC.

Financial Services|Shell Companies|NASDAQ

$3.01-55.27%

$3.72 (-55.27%) • Feb 14

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $3.31

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for BLAC

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.53

52W High$13.40

52W Low$3.01

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A
Gross Margin	N/A	N/A	N/A	N/A	N/A
Operating Income	$-3,524,549	$-1,831,000	$-35,388	$-3,308	$-23,810
Net Income	$-2,411,000	$403,780	$-35,388	$-3,308	$-23,812
Net Margin	N/A	N/A	N/A	N/A	N/A
EPS	$-0.54	$0.07	$-0.00	$-0.00	$-0.00

Company Overview

Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.

Visit Website

Earnings History & Surprises

BLAC

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$0.01

Q3 2023

EPS Surprise History

Q4 22

No data

Q3 23

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q3 2023	Sep 30, 2023	—	$0.01	—	—
Q4 2022	Dec 31, 2022	—	$-17694.00	—	—

Frequently Asked Questions about BLAC

What is BLAC's current stock price?

Bellevue Life Sciences Acquisition Corp. (BLAC) is currently trading at $3.01 per share. The stock has moved -55.27% today.

What is the analyst price target for BLAC?

No analyst price targets are currently available for this stock.

What sector is Bellevue Life Sciences Acquisition Corp. in?

Bellevue Life Sciences Acquisition Corp. operates in the Financial Services sector, specifically within the Shell Companies industry. The company is traded on the NASDAQ exchange.

What is BLAC's market cap?

Bellevue Life Sciences Acquisition Corp. has a market capitalization of $0.01 billion, making it a small-cap company.

Does BLAC pay dividends?

No, Bellevue Life Sciences Acquisition Corp. does not currently pay a dividend to shareholders.